In fact, our impression is that the existence of the TGF-β paradox has directed IBD research toward understanding inflammatory mechanisms in order to control them early on and prevent complications, including fibrosis, rather than directly influencing fibrogenesis. This evidence concerns the gene TGFB1 and inflammatory bowel disease.